Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pentoxifylline and Vedolizumab in Crohn's Disease
NCT02953275Phase 1Completed
- Sponsor
- University of Miami
- Start
- Apr 2017
- Primary completion
- Mar 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in Crohn's disease comparing Vedolizumab + Pentoxifylline with Vedolizumab + Placebo (2 arms). Primary endpoint: Proportion of patients in clinical remission at 14 weeks. Started Apr 2017; status: completed.
02
Drugs
pentoxifylline
03
Conditions
Crohn's disease
Beyond the preview
Go deeper on NCT02953275.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02953275.